drugset / Trial / NCT01259128
Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if SER120 nasal spray is well tolerated in 75 years or older nocturic patients.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 500 ng | Intranasal |
| Subject | Desmopressin | Peptide | 750 ng | Intranasal |